Kolon Life Science Acquires Additional 300,000 Shares of Kolon Biotech
[Asia Economy Reporter Heo Kyung-jun] Kolon Life Science, a KOSDAQ-listed company, announced on the 25th that it will additionally acquire 300,000 shares of its biopharmaceutical manufacturing subsidiary Kolon Biotech for approximately 5.6 billion KRW.
After the stock acquisition, Kolon Life Science's stake in Kolon Biotech will reach 100%. The scheduled date for the stock acquisition is the 26th.
Hot Picks Today
"Continuous Groundwater Extraction Causes Mexic...
- "Stock Set to Double: This Company Smiles Every Time a Data Center Is Built [Cli...
- "Is Yours Just Gathering Dust at Home? Millennials & Gen Z Rediscover Digicams O...
- "Going to Seongsu-dong?" Japanese Girl Group Faces Taxi Refusal in Seoul
- "Prime Minister in Underwear?"... Italy's Meloni Posts Herself to Warn of Deepfa...
Kolon Life Science stated that the purpose of this stock acquisition is "to secure liquidity for the subsidiary."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
